Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study

• Auteurs principaux: Tal Brosh-Nissimov (Auteur), Anka Tzur (Auteur), Daniel Grupel (Auteur), Amos Cahan (Auteur), Nir Ma'aravi (Auteur), Maya Heled-Akiva (Auteur), Hasan Jawamis (Auteur), Hanna Leskes (Auteur), Erez Barenboim (Auteur), Nadav Sorek (Auteur)
• Format: Livre
• Publié: BMC, 2023-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background The Accelerate PhenoTest® BC system (AXDX) is a novel assay for rapid bacterial identification and antimicrobial susceptibility (AST). We report an evaluation of its impact on treatment of patients with Gram-negative bacteremia (GNB) with a high risk of antimicrobial resistance (...